Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Convatec Group PLC: Appointment of Joint Corporate Broker


Convatec Group PLC (CTEC)
Convatec Group PLC: Appointment of Joint Corporate Broker

21-Dec-2022 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


 

 

 

 

 

 

 

21 December 2022

Convatec Group Plc

 

Appointment of Joint Corporate Broker

 

Convatec Group Plc, a global medical products and technologies company, today announces the appointment of Citigroup Global Markets Limited as joint corporate broker, to work alongside its existing broker UBS Investment Bank, with immediate effect.

 

 

 

***

 

 

Contacts

 

Analysts & Investors

Kate Postans, Vice President of Investor Relations & Corporate Communications

 

Sheebani Chothani, Investor Relations & Corporate Communications Manager

 

 

+44 (0) 7826 447807

 

 

+44 (0) 7805 011046

 

    [email protected]

Media

Buchanan: Charles Ryland / Chris Lane 

+44 (0)207 466 5000

 



ISIN: GB00BD3VFW73
Category Code: MSCM
TIDM: CTEC
LEI Code: 213800LS272L4FIDOH92
Sequence No.: 210113
EQS News ID: 1518259

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1518259&application_name=news&site_id=sharewise

ConvaTec Group PLC Aktie

2,88 €
1,41 %
Die ConvaTec Group PLC Aktie erlebt heute einen spürbaren Anstieg von 1,41 %.

Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare